Literature DB >> 9491221

Hashimoto thyroiditis is associated with defects of cytochrome-c oxidase in oxyphil Askanazy cells and with the common deletion (4,977) of mitochondrial DNA.

J Müller-Höcker1, U Jacob, P Seibel.   

Abstract

The activity of cytochrome-c oxidase, the terminal enzyme of the respiratory chain (complex IV), was studied at the ultrastructural level in a case of Hashimoto thyroiditis. Cytochrome-c oxidase showed a heterogeneous reaction pattern in oxyphil cells, with scattered foci of oxyphil cells lacking cytochrome-c oxidase staining. In most of the cells the defect involved all the mitochondria, but there were also oxyphil cells with a heterogeneous mitochondrial population characterized by an intracellular coexistence of mitochondria with either intact cytochrome-c oxidase or lacking activity. Immunocytochemistry further disclosed loss of mitochondrially and nuclearly encoded subunits of the enzyme. Molecular genetic analysis of mitochondrial DNA (mtDNA) revealed the presence of the 4977 base pair deletion ("common deletion") of mtDNA (8,482-13,459) in the affected areas but not in normal thyroid tissue of the patient. The amount of deleted mtDNA varied between 2 and 8% of total mtDNA. The results demonstrate that oxyphil cell change in Hashimoto thyroiditis is associated with functional and molecular genetic defects of the respiratory chain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9491221     DOI: 10.3109/01913129809032263

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  10 in total

Review 1.  How to define follicular thyroid carcinoma?

Authors:  Kurt Werner Schmid; Nadir Rashad Farid
Journal:  Virchows Arch       Date:  2006-02-28       Impact factor: 4.064

Review 2.  Mitochondria and cancer.

Authors:  Valdemar Máximo; Jorge Lima; Paula Soares; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2009-04-03       Impact factor: 4.064

3.  Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor.

Authors:  Jürgen Witte; Steffen Lehmann; Michael Wulfert; Quin Yang; Hans D Röher
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

Review 4.  Molecular pathology of well-differentiated thyroid carcinomas.

Authors:  Manuel Sobrinho-Simões; Ana Preto; Ana Sofia Rocha; Patrícia Castro; Valdemar Máximo; Elsa Fonseca; Paula Soares
Journal:  Virchows Arch       Date:  2005-09-28       Impact factor: 4.064

5.  Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.

Authors:  Valdemar Máximo; Paula Soares; Jorge Lima; José Cameselle-Teijeiro; Manuel Sobrinho-Simões
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 6.  Relevance of mitochondrial genetics and metabolism in cancer development.

Authors:  Giuseppe Gasparre; Anna Maria Porcelli; Giorgio Lenaz; Giovanni Romeo
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

7.  Mitochondria, oxidative DNA damage, and aging.

Authors:  R M Anson; V A Bohr
Journal:  J Am Aging Assoc       Date:  2000-10

8.  Clinico-pathological features of a series of 11 oncocytic endocrine tumours of the pancreas.

Authors:  Marco Volante; Stefano La Rosa; Isabella Castellano; Giovanna Finzi; Carlo Capella; Gianni Bussolati
Journal:  Virchows Arch       Date:  2006-02-21       Impact factor: 4.064

9.  Proliferative activity of oxyphilic (Hurthle) cells in reactive and neoplastic thyroid lersions.

Authors:  M S Tretiakova; M Papotti; G Bussolati
Journal:  Endocr Pathol       Date:  1999-06       Impact factor: 3.943

10.  A new phenotype of mitochondrial disease characterized by familial late-onset predominant axial myopathy and encephalopathy.

Authors:  Yusuke Sakiyama; Yuji Okamoto; Itsuro Higuchi; Yukie Inamori; Yoko Sangatsuda; Kumiko Michizono; Osamu Watanabe; Hideyuki Hatakeyama; Yu-ichi Goto; Kimiyoshi Arimura; Hiroshi Takashima
Journal:  Acta Neuropathol       Date:  2011-03-22       Impact factor: 17.088

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.